CDTX Cidara Therapeutics | $19.70
+30.3% | 4/25/2024 | Reiterated by | WBB Securities | - | Strong-Buy -> Strong-Buy | $40.00 | Low | View details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 4/25/2024 |
CDTX Cidara Therapeutics | $19.70
+30.3% | 9/22/2021 | Upgraded by | WBB Securities | - | Buy -> Strong-Buy | $125.00 | High | View details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 9/22/2021 |
OMER Omeros | $7.07
+17.2% | 6/18/2021 | Target Raised by | WBB Securities | - | Strong-Buy | $75.00 -> $100.00 | Medium | View details for WBB Securities rating of Omeros (NASDAQ:OMER) on 6/18/2021 |
ARCT Arcturus Therapeutics | $17.22
+6.5% | 6/9/2020 | Downgraded by | WBB Securities | - | Buy -> Hold | $31.00 | Low | View details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 6/9/2020 |
CDTX Cidara Therapeutics | $19.70
+30.3% | 12/4/2019 | Upgraded by | WBB Securities | - | Speculative Buy -> Buy | $125.00 | Medium | View details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 12/4/2019 |
ADMA ADMA Biologics | $21.38
+0.0% | 4/4/2019 | Upgraded by | WBB Securities | - | Buy | | Low | View details for WBB Securities rating of ADMA Biologics (NASDAQ:ADMA) on 4/4/2019 |
|
MRKR Marker Therapeutics | $3.14
-1.3% | 3/29/2019 | Upgraded by | WBB Securities | - | Buy -> Strong-Buy | $7.29 | High | View details for WBB Securities rating of Marker Therapeutics (NASDAQ:MRKR) on 3/29/2019 |
ARCT Arcturus Therapeutics | $17.22
+6.5% | 9/20/2018 | Upgraded by | WBB Securities | - | Buy -> Strong-Buy | | Low | View details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 9/20/2018 |
SRPT Sarepta Therapeutics | $110.83
0.0% | 6/20/2018 | Reiterated by | WBB Securities | - | Buy | | Low | View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 6/20/2018 |
ARCT Arcturus Therapeutics | $17.22
+6.5% | 6/11/2018 | Upgraded by | WBB Securities | - | Hold -> Buy | | Medium | View details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 6/11/2018 |
CDTX Cidara Therapeutics | $19.70
+30.3% | 5/23/2018 | Upgraded by | WBB Securities | - | Hold -> Buy | | Medium | View details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 5/23/2018 |
OMER Omeros | $7.07
+17.2% | 3/26/2018 | Reiterated by | WBB Securities | - | Buy | $75.00 | High | View details for WBB Securities rating of Omeros (NASDAQ:OMER) on 3/26/2018 |
CLDX Celldex Therapeutics | $26.75
+1.3% | 12/6/2017 | Reiterated by | WBB Securities | - | Buy | $150.00 | Low | View details for WBB Securities rating of Celldex Therapeutics (NASDAQ:CLDX) on 12/6/2017 |
ARCT Arcturus Therapeutics | $17.22
+6.5% | 10/9/2017 | Upgraded by | WBB Securities | - | Hold -> Buy | $2.00 | N/A | View details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 10/9/2017 |
LIVN LivaNova | $51.18
+2.3% | 8/15/2017 | Downgraded by | WBB Securities | - | Hold -> Sell | $50.00 | Low | View details for WBB Securities rating of LivaNova (NASDAQ:LIVN) on 8/15/2017 |
CDTX Cidara Therapeutics | $19.70
+30.3% | 8/11/2017 | Upgraded by | WBB Securities | - | Sell -> Hold | | Low | View details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 8/11/2017 |
OMER Omeros | $7.07
+17.2% | 6/14/2017 | Reiterated by | WBB Securities | - | Strong-Buy | $75.00 | High | View details for WBB Securities rating of Omeros (NASDAQ:OMER) on 6/14/2017 |
OMER Omeros | $7.07
+17.2% | 3/30/2017 | Reiterated by | WBB Securities | - | Buy | $75.00 | Medium | View details for WBB Securities rating of Omeros (NASDAQ:OMER) on 3/30/2017 |
CDTX Cidara Therapeutics | $19.70
+30.3% | 2/22/2017 | Upgraded by | WBB Securities | - | Sell -> Hold | $145.00 | N/A | View details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 2/22/2017 |
OMER Omeros | $7.07
+17.2% | 11/17/2016 | Reiterated by | WBB Securities | Analyst Stephen Brozak | Buy | $75.00 | N/A | View details for WBB Securities rating of Omeros (NASDAQ:OMER) on 11/17/2016 |
ARCT Arcturus Therapeutics | $17.22
+6.5% | 11/2/2016 | Upgraded by | WBB Securities | - | Sell -> Hold | $4.00 -> $1.90 | N/A | View details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 11/2/2016 |
OMER Omeros | $7.07
+17.2% | 10/17/2016 | Reiterated by | WBB Securities | Analyst Stephen Brozak | Buy | $75.00 | N/A | View details for WBB Securities rating of Omeros (NASDAQ:OMER) on 10/17/2016 |
SCYX SCYNEXIS | $1.21
+2.5% | 10/7/2016 | Upgraded by | WBB Securities | - | Buy -> Strong-Buy | $80.00 | N/A | View details for WBB Securities rating of SCYNEXIS (NASDAQ:SCYX) on 10/7/2016 |
CDTX Cidara Therapeutics | $19.70
+30.3% | 9/23/2016 | Downgraded by | WBB Securities | - | Hold -> Sell | $210.00 | N/A | View details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 9/23/2016 |
SRPT Sarepta Therapeutics | $110.83
0.0% | 9/20/2016 | Reiterated by | WBB Securities | Analyst Stephen Brozak | Strong-Buy | $40.00 -> $60.00 | N/A | View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 9/20/2016 |
ARCT Arcturus Therapeutics | $17.22
+6.5% | 9/12/2016 | Downgraded by | WBB Securities | - | Hold -> Sell | $5.00 -> $4.00 | N/A | View details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 9/12/2016 |
LIVN LivaNova | $51.18
+2.3% | 8/31/2016 | Reiterated by | WBB Securities | - | Hold | $60.00 | N/A | View details for WBB Securities rating of LivaNova (NASDAQ:LIVN) on 8/31/2016 |
SCYX SCYNEXIS | $1.21
+2.5% | 8/9/2016 | Upgraded by | WBB Securities | - | Speculative Buy -> Buy | $80.00 | N/A | View details for WBB Securities rating of SCYNEXIS (NASDAQ:SCYX) on 8/9/2016 |
OMER Omeros | $7.07
+17.2% | 6/14/2016 | Reiterated by | WBB Securities | - | Buy | $75.00 | N/A | View details for WBB Securities rating of Omeros (NASDAQ:OMER) on 6/14/2016 |
SRPT Sarepta Therapeutics | $110.83
0.0% | 6/8/2016 | Reiterated by | WBB Securities | Analyst Stephen Brozak | Buy | $40.00 | N/A | View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 6/8/2016 |
SRPT Sarepta Therapeutics | $110.83
0.0% | 5/2/2016 | Reiterated by | WBB Securities | Analyst Stephen Brozak | Strong-Buy | $40.00 | N/A | View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 5/2/2016 |
SRPT Sarepta Therapeutics | $110.83
0.0% | 4/26/2016 | Reiterated by | WBB Securities | Analyst Stephen Brozak | Buy | $40.00 | N/A | View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 4/26/2016 |
SRPT Sarepta Therapeutics | $110.83
0.0% | 3/30/2016 | Reiterated by | WBB Securities | Analyst Stephen Brozak | Buy | $40.00 | N/A | View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 3/30/2016 |
TZOO Travelzoo | $19.24
+3.9% | 2/17/2016 | Initiated by | WBB Securities | - | Speculative Buy | $11.00 | N/A | View details for WBB Securities rating of Travelzoo (NASDAQ:TZOO) on 2/17/2016 |
SCYX SCYNEXIS | $1.21
+2.5% | 1/4/2016 | Initiated by | WBB Securities | Analyst Stephen Brozak | Buy | $80.00 | N/A | View details for WBB Securities rating of SCYNEXIS (NASDAQ:SCYX) on 1/4/2016 |
SCYX SCYNEXIS | $1.21
+2.5% | 12/29/2015 | Initiated by | WBB Securities | - | Buy | $80.00 | N/A | View details for WBB Securities rating of SCYNEXIS (NASDAQ:SCYX) on 12/29/2015 |
SRPT Sarepta Therapeutics | $110.83
0.0% | 11/22/2015 | Reiterated by | WBB Securities | Analyst Stephen Brozak | Buy | $40.00 | N/A | View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 11/22/2015 |
CTSO Cytosorbents | $0.90
-1.7% | 10/29/2015 | Upgraded by | WBB Securities | - | Speculative Buy -> Buy | $13.00 | N/A | View details for WBB Securities rating of Cytosorbents (NASDAQ:CTSO) on 10/29/2015 |
CDTX Cidara Therapeutics | $19.70
+30.3% | 10/9/2015 | Upgraded by | WBB Securities | - | Sell -> Hold | $260.00 | N/A | View details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 10/9/2015 |
OMER Omeros | $7.07
+17.2% | 8/18/2015 | Target Raised by | WBB Securities | - | Strong-Buy | $60.00 -> $75.00 | N/A | View details for WBB Securities rating of Omeros (NASDAQ:OMER) on 8/18/2015 |
2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad) The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget!
We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months. 👉[Click here to get your FREE report delivered instantly!] |
OMER Omeros | $7.07
+17.2% | 8/18/2015 | Reiterated by | WBB Securities | - | Buy | $60.00 | N/A | View details for WBB Securities rating of Omeros (NASDAQ:OMER) on 8/18/2015 |
SRPT Sarepta Therapeutics | $110.83
0.0% | 8/13/2015 | Reiterated by | WBB Securities | Analyst Stephen Brozak | Buy | $35.00 -> $40.00 | N/A | View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 8/13/2015 |
ARCT Arcturus Therapeutics | $17.22
+6.5% | 8/9/2015 | Reiterated by | WBB Securities | - | Hold | $5.00 | N/A | View details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 8/9/2015 |
ARCT Arcturus Therapeutics | $17.22
+6.5% | 6/24/2015 | Downgraded by | WBB Securities | - | Speculative Buy -> Hold | $5.00 | N/A | View details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 6/24/2015 |
CLDX Celldex Therapeutics | $26.75
+1.3% | 6/1/2015 | Reiterated by | WBB Securities | Analyst Stephen Brozak | Buy | $450.00 -> $600.00 | N/A | View details for WBB Securities rating of Celldex Therapeutics (NASDAQ:CLDX) on 6/1/2015 |
SRPT Sarepta Therapeutics | $110.83
0.0% | 5/22/2015 | Reiterated by | WBB Securities | Analyst Stephen Brozak | Strong-Buy | $25.00 -> $35.00 | N/A | View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 5/22/2015 |
CDTX Cidara Therapeutics | $19.70
+30.3% | 4/23/2015 | Initiated by | WBB Securities | - | Sell | $260.00 | N/A | View details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 4/23/2015 |
CTSO Cytosorbents | $0.90
-1.7% | 2/25/2015 | Initiated by | WBB Securities | - | Speculative Buy | $13.00 | N/A | View details for WBB Securities rating of Cytosorbents (NASDAQ:CTSO) on 2/25/2015 |
SRPT Sarepta Therapeutics | $110.83
0.0% | 1/15/2015 | Reiterated by | WBB Securities | Analyst Stephen Brozak | Buy | | N/A | View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 1/15/2015 |
SRPT Sarepta Therapeutics | $110.83
0.0% | 11/26/2014 | Upgraded by | WBB Securities | Analyst Stephen Brozak | Buy -> Strong-Buy | $25.00 | N/A | View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 11/26/2014 |
SRPT Sarepta Therapeutics | $110.83
0.0% | 7/29/2014 | Upgraded by | WBB Securities | Analyst Stephen Brozak | Speculative Buy -> Buy | | N/A | View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 7/29/2014 |
SRPT Sarepta Therapeutics | $110.83
0.0% | 7/29/2014 | Target Raised by | WBB Securities | Analyst Stephen Brozak | Speculative Buy -> Buy | $25.00 | N/A | View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 7/29/2014 |
ARCT Arcturus Therapeutics | $17.22
+6.5% | 6/26/2014 | Initiated by | WBB Securities | - | Hold | $18.00 | N/A | View details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 6/26/2014 |
OMER Omeros | $7.07
+17.2% | 4/7/2014 | Target Raised by | WBB Securities | - | Strong-Buy | $20.00 -> $30.00 | N/A | View details for WBB Securities rating of Omeros (NASDAQ:OMER) on 4/7/2014 |
SRPT Sarepta Therapeutics | $110.83
0.0% | 11/26/2013 | Upgraded by | WBB Securities | - | Sell -> Speculative Buy | $9.00 -> $19.00 | N/A | View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 11/26/2013 |
PATH UiPath | $13.69
+6.4% | 1/22/2013 | Upgraded by | WBB Securities | - | Buy -> Strong-Buy | $7.00 | N/A | View details for WBB Securities rating of UiPath (NYSE:PATH) on 1/22/2013 |
SSKN STRATA Skin Sciences | $3.10
+0.3% | 9/24/2012 | Upgraded by | WBB Securities | - | Hold -> Speculative Buy | $200.00 -> $400.00 | N/A | View details for WBB Securities rating of STRATA Skin Sciences (NASDAQ:SSKN) on 9/24/2012 |
SRPT Sarepta Therapeutics | $110.83
0.0% | 9/12/2012 | Downgraded by | WBB Securities | - | Hold -> Sell | $8.00 -> $9.00 | N/A | View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 9/12/2012 |
BCRX BioCryst Pharmaceuticals | $7.45
+2.1% | 8/14/2012 | Downgraded by | WBB Securities | - | Buy -> Hold | $8.50 -> $4.40 | N/A | View details for WBB Securities rating of BioCryst Pharmaceuticals (NASDAQ:BCRX) on 8/14/2012 |
SRPT Sarepta Therapeutics | $110.83
0.0% | 8/9/2012 | Initiated by | WBB Securities | - | Buy -> Hold | $8.00 | N/A | View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 8/9/2012 |
VCEL Vericel | $57.86
+1.0% | 7/24/2012 | Upgraded by | WBB Securities | - | Buy -> Strong-Buy | $3.00 -> $3.00 | N/A | View details for WBB Securities rating of Vericel (NASDAQ:VCEL) on 7/24/2012 |
VCEL Vericel | $57.86
+1.0% | 6/4/2012 | Upgraded by | WBB Securities | - | Speculative Buy -> Buy | $3.00 | N/A | View details for WBB Securities rating of Vericel (NASDAQ:VCEL) on 6/4/2012 |
VCEL Vericel | $57.86
+1.0% | 4/16/2012 | Upgraded by | WBB Securities | - | Hold -> Speculative Buy | $2.50 -> $3.00 | N/A | View details for WBB Securities rating of Vericel (NASDAQ:VCEL) on 4/16/2012 |
OMER Omeros | $7.07
+17.2% | 3/22/2012 | Target Raised by | WBB Securities | - | Strong-Buy | $10.50 -> $20.00 | N/A | View details for WBB Securities rating of Omeros (NASDAQ:OMER) on 3/22/2012 |
JAZZ Jazz Pharmaceuticals | $124.67
+4.6% | 12/8/2011 | Downgraded by | WBB Securities | - | Buy -> Hold | $15.00 -> $40.00 | N/A | View details for WBB Securities rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 12/8/2011 |
VCEL Vericel | $57.86
+1.0% | 12/6/2011 | Upgraded by | WBB Securities | - | Sell -> Hold | $2.00 -> $2.50 | N/A | View details for WBB Securities rating of Vericel (NASDAQ:VCEL) on 12/6/2011 |
GERN Geron | $4.01
+0.5% | 11/16/2011 | Downgraded by | WBB Securities | - | Strong Buy -> Buy | $19.00 -> $6.00 | N/A | View details for WBB Securities rating of Geron (NASDAQ:GERN) on 11/16/2011 |
MBOT Microbot Medical | $0.91
-1.4% | 7/7/2011 | Initiated by | WBB Securities | - | Sell | $36.00 | N/A | View details for WBB Securities rating of Microbot Medical (NASDAQ:MBOT) on 7/7/2011 |
EBS Emergent BioSolutions | $9.51
+7.1% | 5/31/2011 | Target Raised by | WBB Securities | - | Strong Buy | $20.50 -> $30.00 | N/A | View details for WBB Securities rating of Emergent BioSolutions (NYSE:EBS) on 5/31/2011 |
PLX Protalix BioTherapeutics | $1.63
-3.6% | 3/17/2011 | Downgraded by | WBB Securities | - | Strong-Buy -> Buy | $100.00 | N/A | View details for WBB Securities rating of Protalix BioTherapeutics (NYSE:PLX) on 3/17/2011 |
VCEL Vericel | $57.86
+1.0% | 2/9/2011 | Initiated by | WBB Securities | - | Sell | $2.00 | N/A | View details for WBB Securities rating of Vericel (NASDAQ:VCEL) on 2/9/2011 |
OSIR Osiris Therapeutics | $18.99
| 1/31/2011 | Downgraded by | WBB Securities | - | Sell -> Sell Short | $5.00 -> $5.00 | N/A | View details for WBB Securities rating of Osiris Therapeutics (OTCMKTS:OSIR) on 1/31/2011 |
SRPT Sarepta Therapeutics | $110.83
0.0% | 12/29/2010 | Initiated by | WBB Securities | - | Speculative Buy | $3.00 | N/A | View details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 12/29/2010 |
